Cargando…

The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation—A Monocentric Cross-Sectional Pilot Study

Background and Objectives: The present study aims to analyze the complex patient/treating physician interaction at onset of botulinum toxin (BoNT) therapy in patients with idiopathic cervical dystonia (CD) and the influence of high initial doses on long-term outcomes. Materials and Methods: A total...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hefter, Harald, Schomaecker, Isabelle, Schomaecker, Max, Rosenthal, Dietmar, Samadzadeh, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779899/ https://www.ncbi.nlm.nih.gov/pubmed/35056396 http://dx.doi.org/10.3390/medicina58010088

Ejemplares similares

The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia
por: Hefter, Harald, et al.
Publicado: (2021)

Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy
por: Hefter, Harald, et al.
Publicado: (2020)

Lessons about Botulinum Toxin A Therapy from Cervical Dystonia Patients Drawing the Course of Disease: A Pilot Study
por: Hefter, Harald, et al.
Publicado: (2023)

The Extreme Ends of the Treatment Response Spectrum to Botulinum Toxin in Cervical Dystonia
por: Samadzadeh, Sara, et al.
Publicado: (2020)

Comparing soleus injections and gastrocnemius injections of botulinum toxin for treating adult spastic foot drop: a monocentric observational study
por: Hefter, Harald, et al.
Publicado: (2021)

Clinical relevance of neutralizing antibodies in botulinum toxin long-term treated still-responding patients with cervical dystonia
por: Hefter, Harald, et al.
Publicado: (2019)

Clinical Improvement After Treatment With IncobotulinumtoxinA (XEOMIN®) in Patients With Cervical Dystonia Resistant to Botulinum Toxin Preparations Containing Complexing Proteins
por: Hefter, Harald, et al.
Publicado: (2021)

Exploring the Interplay between the Clinical and Presumed Effect of Botulinum Injections for Cervical Dystonia: A Pilot Study
por: Hefter, Harald, et al.
Publicado: (2023)

The impact of the initial severity on later outcome: retrospective analysis of a large cohort of botulinum toxin naïve patients with idiopathic cervical dystonia
por: Hefter, Harald, et al.
Publicado: (2020)

“Pseudo”-Secondary Treatment Failure Explained via Disease Progression and Effective Botulinum Toxin Therapy: A Pilot Simulation Study
por: Hefter, Harald, et al.
Publicado: (2023)

The complex relationship between antibody titers and clinical outcome in botulinum toxin type A long-term treated patients with cervical dystonia
por: Hefter, Harald, et al.
Publicado: (2022)

Very early reduction in efficacy of botulinum toxin therapy for cervical dystonia in patients with subsequent secondary treatment failure: a retrospective analysis
por: Hefter, Harald, et al.
Publicado: (2013)

The Impact of SARS-CoV-2 Pandemic Lockdown on a Botulinum Toxin Outpatient Clinic in Germany
por: Samadzadeh, Sara, et al.
Publicado: (2021)

Enhanced Effect of Botulinum Toxin A Injections into the Extensor Digitorum Brevis Muscle after Local Mechanical Leg Vibration: A Case Report
por: Hefter, Harald, et al.
Publicado: (2021)

Significant Long-Lasting Improvement after Switch to Incobotulinum Toxin in Cervical Dystonia Patients with Secondary Treatment Failure
por: Hefter, Harald, et al.
Publicado: (2022)

Continuous Increase of Efficacy under Repetitive Injections of Botulinum Toxin Type/A beyond the First Treatment for Adult Spastic Foot Drop
por: Hefter, Harald, et al.
Publicado: (2021)

Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy
por: Jost, Wolfgang H., et al.
Publicado: (2012)

Effective long-term treatment with incobotulinumtoxin (Xeomin®) without neutralizing antibody induction: a monocentric, cross-sectional study
por: Hefter, Harald, et al.
Publicado: (2020)

Analysis of Single-Leg Hopping in Long-Term Treated Patients with Neurological Wilson’s Disease: A Controlled Pilot Study
por: Hefter, Harald, et al.
Publicado: (2022)

Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment
por: Camargo, Carlos Henrique Ferreira, et al.
Publicado: (2015)

Botulinum Toxin Therapy for Cervical Dystonia: The Science of Dosing
por: Evidente, Virgilio Gerald H., et al.
Publicado: (2014)

The Necessity of a Locally Active Antidote in the Clinical Practice of Botulinum Neurotoxin Therapy: Short Communication
por: Hefter, Harald, et al.
Publicado: (2022)

Botulinum toxin therapy of dystonia
por: Dressler, Dirk, et al.
Publicado: (2020)

Effective Treatment of Neurological Symptoms with Normal Doses of Botulinum Neurotoxin in Wilson’s Disease: Six Cases and Literature Review
por: Hefter, Harald, et al.
Publicado: (2021)

Botulinum toxin type A in the treatment of patients with cervical dystonia
por: Brashear, Allison
Publicado: (2009)

Effect of Botulinum Toxin on Non-Motor Symptoms in Cervical Dystonia
por: Costanzo, Matteo, et al.
Publicado: (2021)

The Role of Ultrasound for the Personalized Botulinum Toxin Treatment of Cervical Dystonia
por: Fietzek, Urban M., et al.
Publicado: (2021)

Clinical Implications of Difference in Antigenicity of Different Botulinum Neurotoxin Type A Preparations: Clinical Take-Home Messages from Our Research Pool and Literature
por: Samadzadeh, Sara, et al.
Publicado: (2020)

Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement
por: Schramm, Axel, et al.
Publicado: (2014)

Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review
por: Erro, Roberto, et al.
Publicado: (2023)

Mildly Impaired Foot Control in Long-Term Treated Patients with Wilson’s Disease
por: Samadzadeh, Sara, et al.
Publicado: (2021)

Analysis of Running in Wilson’s Disease
por: Samadzadeh, Sara, et al.
Publicado: (2022)

Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A
por: Mills, Reversa R, et al.
Publicado: (2015)

The Effect of Botulinum Toxin on Network Connectivity in Cervical Dystonia: Lessons from Magnetoencephalography
por: Mahajan, Abhimanyu, et al.
Publicado: (2017)

Treatment satisfaction with botulinum toxin: a comparison between blepharospasm and cervical dystonia
por: Leplow, Bernd, et al.
Publicado: (2017)

Spectral EMG Changes in Cervical Dystonia Patients and the Influence of Botulinum Toxin Treatment
por: Nijmeijer, S. W. R., et al.
Publicado: (2017)

Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin
por: Contarino, Maria Fiorella, et al.
Publicado: (2017)

Botulinum toxin injection changes resting state cerebellar connectivity in cervical dystonia
por: Hok, Pavel, et al.
Publicado: (2021)

LIVECHART Patient‐Reported Outcome Tool for Botulinum Toxin Treatment in Cervical Dystonia
por: Chueluecha, Chuenchom, et al.
Publicado: (2022)

Retroform Cervical Dystonia: Target Muscle Selection and Efficacy of Botulinum Toxin Injection
por: Hu, Yaowen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kgej14cf29khebgr3tnb84479m